📅 2026 Update: Changes in Product Liability Law and Your Rights

Since the original article was published, there have been important updates in product liability law and procedures. These changes may affect how claims are filed and processed. The earlier article continues further down the page, providing foundational information on Tamiflu and personal injury law.

🆕 2024 Torts Update

In 2024, the American Law Institute published the Restatement (Third) of Torts: Products Liability. This update refined how product defects are evaluated. It places more emphasis on the risk-utility analysis, which helps determine if a product's design is safe.

💰 Current Legal Fees

The costs of pursuing a product liability case have been consistent. Contingency fees typically range from 33% to 40% of the recovery amount. This percentage depends on the complexity of the case and the jurisdiction where the lawsuit is filed.

⏳ Processing Times

Product liability cases can take a long time to resolve. They may take several months to years to complete. Factors affecting this duration include the complexity of the case, the jurisdiction, and whether it goes to trial.

⚖️ Eligibility Rules and Deadlines

To file a product liability claim, you must show that you were injured by a defective product. The statute of limitations generally ranges from one to four years from the date of injury or discovery of the defect, depending on state laws. Some states, like California, allow two years from the date of injury to file a claim.

📋 Key Points Summary

  • 🆕 New torts update emphasizes risk-utility analysis.
  • 💰 Legal fees remain between 33% and 40%.
  • ⏳ Case durations can vary from months to years.
  • ⚖️ Eligibility requires proof of injury and defect.
  • 📅 Statute of limitations varies by state.

💡 Tips for Navigating Product Liability Claims

Reviewing the details of your situation with your attorney is essential.

📄 Filing a Claim

Begin your product liability lawsuit by filing a complaint in the right state or federal court. Make sure to include details about the defect, your injury, and the damages you are seeking.

🔍 Understanding the Discovery Process

During the discovery phase, you will engage in activities to gather evidence. This includes depositions, interrogatories, and document requests that help support your claim.

👨‍⚖️ Know the Types of Defects

Product defects fall into three categories: design defects, manufacturing defects, and marketing defects. Understanding these categories can help you build a stronger case.

💼 Consider Alternative Dispute Resolution

If you want to resolve your case without going to court, look into alternative dispute resolution (ADR) options like mediation or arbitration. These methods can be less formal and quicker than traditional court proceedings.

📊 Stay Informed About Legal Costs

Be aware of potential costs associated with litigation. This includes court fees, expert witness fees, and attorney's fees, which can add up quickly.

🏆 Free Options Ranked by User Reviews (2026)

No national paid service in this area met the review threshold, so this section lists free government and nonprofit resources.

🥇 1. Legal Services Corporation (LSC)

The Legal Services Corporation (LSC) offers free legal assistance to eligible individuals. It helps those who cannot afford legal services navigate their legal issues, including product liability claims.

🥈 2. Federal Trade Commission (FTC)

The Federal Trade Commission provides resources and guidance on consumer rights and product safety. They offer information on how to report defective products and protect consumer interests.

🥉 3. State Consumer Protection Offices

State consumer protection offices help individuals understand their rights regarding product safety. They provide information on how to file complaints and assist with issues related to defective products.

4️⃣ Consumer Advocacy Groups

Consumer advocacy groups work to protect consumer rights and promote product safety. They often provide resources, educational material, and support for consumers dealing with defective products.

🔎 What to Check Before Paying for Help

  • 📜 Verify the credentials of any organization offering assistance.
  • 💸 Understand all potential costs before committing.
  • 🔍 Read reviews and testimonials from other consumers.
  • 📅 Check for any deadlines related to your claim.

❓ Frequently Asked Questions

❔ What is the burden of proof in product liability cases?

In product liability cases, the plaintiff typically bears the burden of proving the defect and causation. This means they must show that the defect caused their injury.

⚠️ How does the statute of limitations affect my claim?

The statute of limitations sets a time limit on how long you have to file a claim. This period varies by state and typically ranges from one to four years from the date of injury or discovery of the defect.

🏷️ What are punitive damages?

Punitive damages may be awarded in cases of gross negligence or willful misconduct. These damages are designed to punish the defendant and deter future misconduct.

🔄 Can I be partially at fault for my injury?

Yes, in some jurisdictions, if the plaintiff is found partially at fault for their injury, damages may be reduced proportionally. This is known as comparative fault.

📉 What should I know about legal representation?

While it is advisable to consult with an attorney experienced in product liability, knowing your rights and the claims process can empower you in your case.

🛑 How can I report a defective product?

You can report a defective product to the manufacturer and relevant regulatory agencies like the Consumer Product Safety Commission. Staying informed can help prevent future injuries.

⚖️ Recent Court Rulings in Product Liability Cases

Recent court rulings have clarified important aspects of product liability law. These rulings can significantly impact how cases are evaluated and the outcomes for plaintiffs.

For more recent rulings, you can browse more rulings on the news page.

End of October 2026 Update





Tamiflu: The Controversial Flu Medication

Introduction

Influenza, commonly known as the flu, is a contagious respiratory illness caused by influenza viruses. According to the Centers for Disease Control and Prevention (CDC), every year in the United States millions of people get the flu, hundreds of thousands are hospitalized, and thousands die from flu-related illnesses. To combat this disease, researchers developed a medication called Tamiflu, which has been on the market since the 1990s. But what is Tamiflu, and is it effective? This article will explore the history, controversy, and recent developments surrounding Tamiflu.

What is Tamiflu?

Tamiflu (oseltamivir phosphate) is an antiviral medication used to treat and prevent influenza A and B viruses. It works by inhibiting the neuraminidase enzyme, which is necessary for the virus to release itself from infected cells. By blocking this enzyme, Tamiflu can reduce the severity and duration of flu symptoms and possibly prevent complications such as pneumonia, bronchitis, or hospitalization.

Tamiflu

📝 See Also

Development and Approval

Tamiflu was developed in the late 1990s by Gilead Sciences and later marketed by Roche. It was approved by the U.S. Food and Drug Administration (FDA) in 1999 as a prescription medication for treating acute uncomplicated influenza in adults. In 2000, it was also approved for treating flu symptoms in children ages one year and older.

In 2005, after a global outbreak of H5N1 bird flu, also known as avian influenza, the WHO recommended stockpiling Tamiflu as a defense against a potential pandemic. Many countries followed suit and purchased large amounts of Tamiflu to prepare for a possible flu outbreak. According to the CDC, the U.S. Strategic National Stockpile contains more than 31 million doses of Tamiflu.

Effectiveness

The effectiveness of Tamiflu in treating and preventing the flu has been the subject of much debate and controversy. While some studies suggest that Tamiflu can reduce the duration of flu symptoms by one to two days and lower the risk of complications, others question whether it is effective at all.

A 2014 Cochrane review, which analyzed the results of 20 clinical trials involving 26,717 people, found that Tamiflu reduced the duration of flu symptoms by 21 hours compared to placebo, but did not significantly reduce the incidence of hospitalization or pneumonia. The review also raised concerns about the quality of the studies, the lack of access to raw data from Roche, and the potential for publication bias.

In 2012, the British Medical Journal (BMJ) published an article that accused Roche of withholding key clinical trial data on Tamiflu, claiming that the drug was not as effective as previously thought. The BMJ and Cochrane researchers led a campaign to obtain the data from Roche and conducted their own independent analysis. The meta-analysis, published in the BMJ in 2014, concluded that Tamiflu did not significantly reduce the incidence of hospitalization or complications and had a higher risk of side effects such as nausea and vomiting.

Roche, however, disputed the findings and argued that the review was flawed and did not take into account all the available data. In response to the criticism, Roche pledged to release all of its Tamiflu clinical trial data to researchers. In 2015, the Cochrane researchers conducted a new analysis based on the additional data and found that while Tamiflu still reduced the duration of flu symptoms, there was no evidence that it reduced hospitalization or complications. The researchers concluded that the needle has moved little since 2014, and the evidence remains weak.

Side Effects and Safety

Tamiflu is generally well-tolerated, but like any medication, it can cause side effects. The most common side effects of Tamiflu include nausea, vomiting, diarrhea, dizziness, headache, and cough. Some people may experience more severe side effects, such as allergic reactions, seizures, or hallucinations, but these are rare.

There have also been concerns about the safety of Tamiflu, particularly in children and adolescents. In 2006, the FDA issued a warning about the risk of neuropsychiatric side effects such as delirium, hallucinations, and self-harm in patients taking Tamiflu, particularly children. There have been reports of deaths and accidents associated with Tamiflu use, but it is unclear whether these were directly caused by the medication or other factors.

In response to these concerns, the FDA required Roche to add a warning to the Tamiflu label about the risk of neuropsychiatric side effects. Roche also updated the label to include information about the possibility of serious skin reactions and reduced efficacy in patients with influenza who have taken Tamiflu prophylactically.

Recent Developments

In the wake of the COVID-19 pandemic, there has been renewed interest in the use of antiviral medications such as Tamiflu to treat viral illnesses. However, the evidence on the effectiveness of Tamiflu in treating COVID-19 is limited, and it is not currently recommended as a treatment.

In October 2020, the FDA approved the emergency use of Tamiflu in certain hospitalized COVID-19 patients who are at risk for severe illness but not yet requiring ventilation or extracorporeal membrane oxygenation (ECMO). The emergency use authorization was based on limited clinical data and expert opinion, and Tamiflu should only be used under close medical supervision.

Conclusion

Tamiflu is a controversial medication that has been the subject of much debate and scrutiny. While Tamiflu has been shown to reduce the duration of flu symptoms by a small amount, the evidence on its effectiveness in preventing complications and hospitalization is weak. There are also concerns about the safety of Tamiflu, particularly in children and adolescents. Further research is needed to determine the benefits and risks of Tamiflu and to develop better treatments for influenza and other viral illnesses.

References

Centers for Disease Control and Prevention. (2020). Key facts about influenza (flu). https://www.cdc.gov/flu/about/keyfacts.htm

Food and Drug Administration. (1999). Tamiflu label. https://www.accessdata.fda.gov/drugsatfda_docs/label/1999/20919lbl.pdf

Food and Drug Administration. (2018). Tamiflu label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021087s059lbl.pdf

Rawson, T. M., Moore, L. S. P., & Zhu, N. (2020). Tamiflu and COVID-19: a possible role for neuraminidase inhibitors? The Lancet Respiratory Medicine. https://doi.org/10.1016/S2213-2600(20)30327-6

Roche. (2020). Tamiflu (oseltamivir phosphate). https://www.tamiflu.com/

The Cochrane Collaboration. (2014). Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD008965.pub4/full

Science Media Centre. (2014). Expert reaction to BMJ feature on Tamiflu. https://www.sciencemediacentre.org/expert-reaction-to-bmj-feature-on-tamiflu/

World Health Organization. (2005). WHO issues interim guidance for the use of oseltamivir for the prophylaxis and treatment of influenza. https://www.who.int/mediacentre/news/releases/2005/pr38/en/

What is Tamiflu?

Tamiflu, or Oseltamivir is an anti-viral drug developed and manufactured by Roche for the treatment of influenza.  The drug works by inhibiting an enzyme found in host cells.  That inhibition acts to prevent the release of new particles of the influenza virus from being released by the infected host cell.  The drug is approved for use by individuals one year old and over.

Side Effects

Common side effects of Tamiflu include nausea, diarrhea, abdominal pain, and headache.  The rarer and more severe side effects associated with the drug include hepatitis, rash anaphylaxis and Stevens-Johnson syndrome.

One disastrous side effect associated with Tamiflu are neuropsychiatric disorders associated with hallucinations and attempts to hurt oneself and cause harm to others.  In 2007 Japan's health ministry issued a warning about use by individuals between the ages of 10 and 19 after a number of incidents involving teenagers jumping from tall buildings after taking the drug.  A study done by the health ministry later confirmed that teenagers who take Tamiflu are 54% more likely to exhibit abnormal behavior; including hallucinations, than those who did not take the drug.

Government Regulations

Between 2005 and 2006 the FDA received 103 reports, mostly Japanese, that indicated a higher risk of hallucinations than previously expected.  Due to this the FDA required a label change on Tamiflu packets indicating the possible side effects could include hallucinations, delirium and other unusual behaviors.  In its defense Roche has commented that of the massive amount of people who get influenza every year it is more likely that the flu itself is responsible for the hallucinations, not Tamiflu.  Roche has recently lowered the recommended dosage of Tamiflu in half, from 12mg/ml to 6mg/ml, due in part to FDA reports.

Litigation

If you or someone you know has taken Tamiflu and displayed adverse reactions including hallucinations and other abnormal behaviors you should stop the drug immediately.  If you have been injured do to actions taken while on Tamiflu or you have suffered severe side effects including Stevens Johnson disease then you should consult an attorney about possible legal action against Roche.  In an injury action it could be determined that Roche should have known that a high dose of Tamiflu might lead to adverse reactions.  The recent decrease in dosage is circumstantial evidence of this.